High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11
- Zhangzhou Huang 1, Gen Lin 1, Yaping Hong 1, Lihong Weng 1, Kai Zhu 1, Wu Zhuang 1
- Zhangzhou Huang 1, Gen Lin 1, Yaping Hong 1
- 1Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- 0Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Upregulating AlkB homolog 5 (ALKBH5) in non-small cell lung cancer (NSCLC) reduces tumor growth. ALKBH5 promotes ferroptosis by decreasing m6A modification of SLC7A11, inhibiting NSCLC progression.
Area Of Science
- Oncology
- Molecular Biology
- Epigenetics
Background
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
- AlkB homolog 5 (ALKBH5) is recognized for its tumor-suppressive functions in various cancers.
- The specific role of ALKBH5 in NSCLC pathogenesis remains to be fully elucidated.
Purpose Of The Study
- To investigate the functional role of ALKBH5 in the development of non-small cell lung cancer.
- To explore the underlying molecular mechanisms, including the interaction between ALKBH5, SLC7A11, and ferroptosis in NSCLC.
Main Methods
- Expression analysis of ALKBH5 in NSCLC using TCGA database and cell lines.
- Investigated the effects of ALKBH5 and SLC7A11 modulation on NSCLC cell behaviors (viability, apoptosis, migration, invasion).
- Assessed ferroptosis markers, N6-methyladenosine (m6A) modification, and in vivo tumor growth.
Main Results
- ALKBH5 was found to be downregulated in NSCLC.
- ALKBH5 overexpression suppressed NSCLC cell proliferation, migration, and invasion while enhancing apoptosis.
- ALKBH5 inhibited SLC7A11 expression via reduced m6A modification, promoting ferroptosis and suppressing tumor growth in vivo.
Conclusions
- ALKBH5 upregulation inhibits NSCLC progression by promoting ferroptosis.
- This occurs through the downregulation of SLC7A11 transcription mediated by decreased m6A modification.
- ALKBH5 acts as a tumor suppressor in NSCLC by modulating ferroptosis pathways.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
01:22
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

